BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 33028660)

  • 1. Heparan Sulfate Synthesized by
    Ohkawa Y; Wade A; Lindberg OR; Chen KY; Tran VM; Brown SJ; Kumar A; Kalita M; James CD; Phillips JJ
    Mol Cancer Res; 2021 Jan; 19(1):150-161. PubMed ID: 33028660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutation in the heparan sulfate biosynthesis enzyme EXT1 influences growth factor signaling and fibroblast interactions with the extracellular matrix.
    Osterholm C; Barczyk MM; Busse M; Grønning M; Reed RK; Kusche-Gullberg M
    J Biol Chem; 2009 Dec; 284(50):34935-43. PubMed ID: 19850926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The plasticity of oncogene addiction: implications for targeted therapies directed to receptor tyrosine kinases.
    Pillay V; Allaf L; Wilding AL; Donoghue JF; Court NW; Greenall SA; Scott AM; Johns TG
    Neoplasia; 2009 May; 11(5):448-58, 2 p following 458. PubMed ID: 19412429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparan Sulfate Biosynthetic System Is Inhibited in Human Glioma Due to EXT1/2 and HS6ST1/2 Down-Regulation.
    Ushakov VS; Tsidulko AY; de La Bourdonnaye G; Kazanskaya GM; Volkov AM; Kiselev RS; Kobozev VV; Kostromskaya DV; Gaytan AS; Krivoshapkin AL; Aidagulova SV; Grigorieva EV
    Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29104277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparan Sulfate Glycosaminoglycans in Glioblastoma Promote Tumor Invasion.
    Tran VM; Wade A; McKinney A; Chen K; Lindberg OR; Engler JR; Persson AI; Phillips JJ
    Mol Cancer Res; 2017 Nov; 15(11):1623-1633. PubMed ID: 28778876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LRIG2 promotes the proliferation and cell cycle progression of glioblastoma cells in vitro and in vivo through enhancing PDGFRβ signaling.
    Xiao Q; Dong M; Cheng F; Mao F; Zong W; Wu K; Wang H; Xie R; Wang B; Lei T; Guo D
    Int J Oncol; 2018 Sep; 53(3):1069-1082. PubMed ID: 30015847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting LRIG2 overcomes resistance to EGFR inhibitor in glioblastoma by modulating GAS6/AXL/SRC signaling.
    Dong M; Xiao Q; Hu J; Cheng F; Zhang P; Zong W; Tang Q; Li X; Mao F; He Y; Yu X; Wan F; Lei T; Guo D; Wang B
    Cancer Gene Ther; 2020 Dec; 27(12):878-897. PubMed ID: 31988476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparan sulfate sulfatase SULF2 regulates PDGFRα signaling and growth in human and mouse malignant glioma.
    Phillips JJ; Huillard E; Robinson AE; Ward A; Lum DH; Polley MY; Rosen SD; Rowitch DH; Werb Z
    J Clin Invest; 2012 Mar; 122(3):911-22. PubMed ID: 22293178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intratumoral heterogeneity of receptor tyrosine kinases EGFR and PDGFRA amplification in glioblastoma defines subpopulations with distinct growth factor response.
    Szerlip NJ; Pedraza A; Chakravarty D; Azim M; McGuire J; Fang Y; Ozawa T; Holland EC; Huse JT; Jhanwar S; Leversha MA; Mikkelsen T; Brennan CW
    Proc Natl Acad Sci U S A; 2012 Feb; 109(8):3041-6. PubMed ID: 22323597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of multiple ERBB family receptors mediates glioblastoma cancer stem-like cell resistance to EGFR-targeted inhibition.
    Clark PA; Iida M; Treisman DM; Kalluri H; Ezhilan S; Zorniak M; Wheeler DL; Kuo JS
    Neoplasia; 2012 May; 14(5):420-8. PubMed ID: 22745588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EGFR signaling in the HGG-02 glioblastoma cell line with an unusual loss of EGFR gene copy.
    Skoda J; Neradil J; Zitterbart K; Sterba J; Veselska R
    Oncol Rep; 2014 Jan; 31(1):480-7. PubMed ID: 24270553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chondrocytes respond to an altered heparan sulfate composition with distinct changes of heparan sulfate structure and increased levels of chondroitin sulfate.
    Bachvarova V; Dierker T; Esko J; Hoffmann D; Kjellen L; Vortkamp A
    Matrix Biol; 2020 Nov; 93():43-59. PubMed ID: 32201365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibiting receptor tyrosine kinase AXL with small molecule inhibitor BMS-777607 reduces glioblastoma growth, migration, and invasion in vitro and in vivo.
    Onken J; Torka R; Korsing S; Radke J; Krementeskaia I; Nieminen M; Bai X; Ullrich A; Heppner F; Vajkoczy P
    Oncotarget; 2016 Mar; 7(9):9876-89. PubMed ID: 26848524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C3G downregulation induces the acquisition of a mesenchymal phenotype that enhances aggressiveness of glioblastoma cells.
    Manzano S; Gutierrez-Uzquiza A; Bragado P; Sequera C; Herranz Ó; Rodrigo-Faus M; Jauregui P; Morgner S; Rubio I; Guerrero C; Porras A
    Cell Death Dis; 2021 Apr; 12(4):348. PubMed ID: 33824275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of glycosyltransferase PomGnT1 in glioblastoma progression.
    Lan J; Guo P; Lin Y; Mao Q; Guo L; Ge J; Li X; Jiang J; Lin X; Qiu Y
    Neuro Oncol; 2015 Feb; 17(2):211-22. PubMed ID: 25085363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Receptor Tyrosine Kinase Signaling and Targeting in Glioblastoma Multiforme.
    Tilak M; Holborn J; New LA; Lalonde J; Jones N
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33673213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MYST1/KAT8 contributes to tumor progression by activating EGFR signaling in glioblastoma cells.
    Dong Z; Zou J; Li J; Pang Y; Liu Y; Deng C; Chen F; Cui H
    Cancer Med; 2019 Dec; 8(18):7793-7808. PubMed ID: 31691527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparan sulfate regulates hair follicle and sebaceous gland morphogenesis and homeostasis.
    Coulson-Thomas VJ; Gesteira TF; Esko J; Kao W
    J Biol Chem; 2014 Sep; 289(36):25211-26. PubMed ID: 25053416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor efficacy of the heparan sulfate mimic roneparstat (SST0001) against sarcoma models involves multi-target inhibition of receptor tyrosine kinases.
    Cassinelli G; Favini E; Dal Bo L; Tortoreto M; De Maglie M; Dagrada G; Pilotti S; Zunino F; Zaffaroni N; Lanzi C
    Oncotarget; 2016 Jul; 7(30):47848-47863. PubMed ID: 27374103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feedback circuitry between miR-218 repression and RTK activation in glioblastoma.
    Mathew LK; Huangyang P; Mucaj V; Lee SS; Skuli N; Eisinger-Mathason TS; Biju K; Li B; Venneti S; Lal P; Lathia JD; Rich JN; Keith B; Simon MC
    Sci Signal; 2015 May; 8(375):ra42. PubMed ID: 25943352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.